ProKidney Corp. received RMAT designation from the FDA and filed a Current Report on Form 8-K with the SEC.

1 report, 0 independent Updated Jul 2

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

FDA

Keep exploring

Part of

FDA communicated eligibility for accelerated approval for ProKidney Corp., which plans to present study results at ASN. All 1 developments

The entities involved

FDA
- corpuls, a German company, introduced its products at a conference in Fort Worth and is awaiting FDA authorization for U.S. sales.18:39
- Vivos is advancing its product line by securing patents via USPTO filings and gaining unprecedented 510K clearances for an alternative to CPAP technology.18:21

Related events

A company is seeking FDA 510(k) clearance while simultaneously conducting a private placement and qualifying its prospectus in British Columbia.Oct 15

Coverage

Newest first; wire copies grouped

Jul 2Unknown outlet